Lizzy Quinn is a Musculoskeletal Physiotherapist with 20 years experience focusing on people with spinal pain. Australian Health Journal spoke with Lizzy on the complexities of persistent lower back pain in women.
Lower back pain in women in their 30s, 40s, and 50s is complex to treat due to the combination of physical and emotional factors, and health professionals need to stay updated on best practices and science to provide the best recovery platform for patients. These women typically have busy lives, pressures, and expectations.
The Australian Institute of Health and Welfare (AIHW) website states, ‘Mental and behavioural conditions commonly co-occur with musculoskeletal conditions. Compared with people without musculoskeletal conditions, for people aged 45 and over with mental and behavioural conditions were 1.9 times as likely in people with back problems, 1.6 times as likely in people with arthritis and 1.5 times as likely in people with osteoporosis’.
Lizzy believes women with persistent lower back pain need treatment that considers their emotional and physical pain due to the complexity of their lives. Women with lower back pain often try various treatments without realising the impact of their emotional state on their symptoms, making long-term recovery difficult.
Changes in the spine as we age are normal, but the language used in MRI reports can make it concerning for patients, without a healthcare professional providing a through explanation of some of the terms.
Lizzy states, “MRI findings generally provide little information on how to recover from lower back pain, and only a small number of people actually need imaging straight away. For the majority, it won’t change their treatment.”
Getting a lower back MRI may lead to unnecessary worry as normal age-related changes are often misinterpreted as serious issues.
As far as the body is concerned, the brain cannot tell the difference between physical pain and emotional pain, making lower back pain complex to treat.
Lower back pain may be driven by tissue sensitivity and hyper-sensitisation in the brain, rather than just joint issues.
Emotional distress can reactivate sensitisation in the brain, that can cause persistent lower back pain, especially when combined with emotional distress. Sensitised pain centres in the brain, can prolong lower back pain even after physical healing.
Educating patients about the complexity of lower back pain is important, but GPs have limited time to do so, making it challenging for them to convey the message to their clients.
Without this awareness, patients will fail to understand the main drivers of lower back pain that are vital for long term recovery.
You Might also like
-
New clinical research entity first to operate across both Australia and New Zealand
Over the past 30 years, 18,000 clinical trials that have been registered in Australia, with the sector contributing $1.4 billion to Australia’s economy annually. Trials are a critical aspect of evidence-based medicine, and are essential for testing how new treatments, tests and vaccines will work. In New Zealand they contribute $146 million to the New Zealand economy.
To capitalise on this unique position and growth, a coordinated multi-site clinical research operation was missing, until now.
-
Child Dental Benefits Schedule needing greater awareness
Since its launch in 2014, the Child Dental Benefits Schedule has seen a gradual increase in participation year on year. The impact of COVID-19 and related shutdowns saw participation fall sharply in 2020. Though it increased 2021, the national target of 41% participation was not reached in 2021-2022, with the total (35.4%) more than three percent below 2018 participation rates.
In an opinion segment, Australian Health Journal spoke with Abano Healthcare Group Clinical Director, Dr Fred Calavassy, with over 30 years of clinical experience, about his observations of the Child Dental Benefits Scheme ways to increasing participation rates.
-
World-first clinical trial improves patient outcomes for kidney transplants
A world-first clinical trial conducted at the Royal Adelaide Hospital (RAH) and at hospitals across Australia and New Zealand has identified the best fluid treatment to reduce the risk of patients requiring dialysis after a kidney transplant.
Australian Health Journal spoke with the lead-author of the study, RAH Nephrologist and University of Adelaide researcher, Dr Michael Collins.